 |
|
| Blog results | Results 1 - 10 of about 3,627 for capecitabine dosing. (0.29 seconds) |
| Sorted by relevance Sort by date |
| 18 Nov 2009 by Starling, Watkins, Cunningham, Thomas,... Conclusion The maximum-tolerated dose of capecitabine was 1660 mg/m2. The recommended capecitabine dose in this cytotoxic doublet/biologic doublet regimen is 1440 mg/m2; this regimen is under evaluation in an ongoing phase II study. ... Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/ [ More results from Journal of Clinical Oncology Current Issue ] |
| 3 Dec 2009 by admin Dose: subjects can spend well. Respectfully i will deliver some kids of the reason of effective half burying gel, efavirenz therapy, fear, and drug. So pregnant authorities know a bipolar example directed to be framed by those ... Dr Zord's Blog - http://jochenmoser.com/ |
| 19 Nov 2009 PURPOSE: This phase I/II trial is studying the side effects and best dose of conatumumab when given together with gemcitabine hydrochloride, capecitabine, and radiation therapy and to see how well they work in treating patients with ... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 25 Jun 2008 Learn about the prescription medication Xeloda (Capecitabine), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling. RxList - News and Features - http://www.rxlist.com/script/main/hp.asp [ More results from RxList - News and Features ] |
| 2 Dec 2009 by admin Peak nicotine concentrations were similar for cigarette and waterpipe use, but due to the longer duration of waterpipe sessions, “participants were exposed to 1.7 times the nicotine dose” relative to the dose from a cigarette, ... Tobacco Facts. - http://www.tobacco-facts.net/ |
| 22 Sep 2009 by Prne May 5th, 2009 STOCKHOLM - Axelar AB today announced successful completion of the single-day oral dosing part of its ongoing phase I/II clinical trial on cancer patients with its new anti-cancer drug AXL1717,an insulin-like growth ... PR Hub - http://blog.taragana.com/pr/ - References [ More results from PR Hub ] |
| 19 Sep 2009 by Saif MW, Shi N, Zelt S results: we identified 1013 patients with gec: approximately half had treatment initiated with a 5-fu regimen, whereas 11% had therapy initiated with a capecitabine regimen. the mean capecitabine dose overall was 2382 +/- 1118 mg/d, ... journalfeeds - http://journalfeeds.com/ |
| 14 Jun 2009 Take once daily on Days 1–21 continuously with capecitabine (see literature for capecitabine dose) in a repeating 21 day cycle; continue until disease progression or unacceptable toxicity occurs. 1250mg (5 tablets). ... Latest articles from MPR - http://www.empr.com/ [ More results from Latest articles from MPR ] |
| 22 Oct 2009 by Carol There was no need for dose reduction of capecitabine. The henna also had no noticeable side-effects. The scientist surmised that the clinical improvement in these patients may have been due to the anti-inflammatory, antipyretic and ... Healing Pastures - http://healingpastures.com/ |
| 11 Sep 2006 by Leonard, R, O'Shaughnessy, J, Vukelja,... Conclusions: Capecitabine/docetaxel dosing flexibility allows management of side-effects without compromising efficacy. This retrospective analysis, as well as multiple phase II studies of taxanes with reduced-dose capecitabine, ... Annals of Oncology - recent issues - http://annonc.oxfordjournals.org/ [ More results from Annals of Oncology - recent issues ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
